Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fimmu.2026.1928095.s023BackgroundChronic active Epstein-Barr virus disease (CAEBV) is a rare EBV-associated T/NK-cell lymphoproliferative disorder characterized by persistent viral infection, systemic inflammation, and highly variable clinical courses. Patients may develop HLH-like hyperinflammation, severe organ involvement, lymphoma transformation, or death, yet current assessment does not fully explain why patients with similar viral burden follow divergent trajectories.MethodsWe integrated PBMC single-cell RNA-sequencing profiles from healthy controls and CAEBV samples with a retrospective cohort of 130 independent CAEBV patients to connect cellular immune remodeling with clinically measurable features.ResultsSingle-cell analysis identified T/NK remodeling toward cytotoxic, exhaustion-associated, senescence-associated, and metabolically altered states, accompanied by IFN-responsive, antigen-presenting myeloid programs. Ligand-receptor and receiver-side analyses prioritized candidate IFNγ-associated T/NK-to-myeloid communication within this IFN-responsive program, linking NK and CD8+ T-cell states with myeloid inflammatory activation. Guided by these findings, we mapped inflammatory, metabolic, coagulation, and lymphocyte-subset variables into a biology-informed clinical immunometabolic index reflecting inflammatory cytokine activation, metabolic stress, and adaptive immune contraction. Internally defined index strata were associated with increasing CAEBV+HLH, death, and severe-disease burden. Unsupervised clinical mapping further identified three exploratory but interpretable immunometabolic patterns, including immune-metabolically preserved, intermediate immune-contraction, and IFNγ-high immunometabolic high-risk, with distinct immune-cell, inflammatory, metabolic, and outcome profiles.ConclusionsTogether, these findings organize CAEBV heterogeneity around linked T/NK remodeling, myeloid activation, and systemic immunometabolic stress. This single-cell-informed clinical-pattern map complements EBV-DNA and organ-size assessment and supports prospective validation of clinically measurable, mechanism-guided monitoring and intervention strategies.
Keyword(s):
chronic active Epstein-Barr virus disease (CAEBV); clinical cohort; clinical phenotypes; Genetic Immunology; IFN-responsive myeloid activation.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)